Delivery Order SPE2DR25D2005-SPE2DR26FE6D4
Award Date 11/4/25
Potential Completion Date 11/26/25
Potential Value $2.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,670.91 to AmerisourceBergen Drug Corp for ProQuad vials on October 29, 2025, with completion scheduled by November 20, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. ProQuad is a combination vaccine for measles, mumps, rubella, and varicella, supporting the federal government's immunization and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,140.38 to AmerisourceBergen Drug Corp for ProQuad vials on August 11, 2025, with a completion date of September 2, 2025. This competitively awarded, firm fixed-price delivery order supports federal medical procurement needs and is being performed at the contractor's facility in Conshohocken, Pennsylvania. ProQuad is a combination vaccine providing immunity against measles, mumps, rubella, and varicella, making this order...
- The Defense Logistics Agency awarded a delivery order valued at $5,480.80 to AmerisourceBergen Drug Corp for ProQuad vials, a combination vaccine product. The contract, issued on September 10, 2025, with an ultimate completion date of October 1, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will take place at the contractor's corporate office location in Conshohocken, Pennsylvania. This award is a child order under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order valued at $13,499.84 to AmerisourceBergen Drug Corp for ProQuad vials on August 25, 2025, with completion targeted for September 16, 2025. This firm fixed-price delivery order represents a non-competitive set-aside and will be performed at the contractor's facility in Conshohocken, Pennsylvania. ProQuad is a combination vaccine providing immunity against measles, mumps, rubella, and varicella, making this order part of the federal...
- The Defense Logistics Agency awarded a $2,686.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ProQuad vials on August 14, 2025, with an ultimate completion date of September 5, 2025. This contract represents a non-competitive delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. ProQuad is a combination vaccine protecting against measles, mumps, rubella, and...
- The Defense Logistics Agency awarded a delivery order valued at $2,686.44 to AmerisourceBergen Drug Corp for ProQuad vials on September 25, 2025, with an ultimate completion date of October 17, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitively awarded procurement under the company's existing DLA contract vehicle. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, the company's...
- The Defense Logistics Agency awarded a delivery order valued at $1,654.33 to AmerisourceBergen Drug Corp for ProQuad vials, with an ultimate completion date of September 10, 2025. This firm fixed-price delivery order represents a non-competitive award issued under an existing contract vehicle and will be performed at the contractor's facility in Conshohocken, Pennsylvania. ProQuad is a combination vaccine used for immunization against measles, mumps, rubella, and varicella, making this...
- The Defense Logistics Agency awarded a $13,367.20 delivery order to AmerisourceBergen Drug Corp for ProQuad vials on September 16, 2025, with an ultimate completion date of October 7, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. ProQuad is a combination vaccine used for immunization against measles, mumps, rubella, and varicella, representing a...
- The Defense Logistics Agency awarded a $5,062.32 delivery order to AmerisourceBergen Drug Corp for ProQuad vials, with an ultimate completion date of September 4, 2025. This non-competitive delivery order was issued under a firm fixed-price arrangement and represents a routine pharmaceutical procurement from the DLA Medical Supply Chain. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued against...
- The Defense Logistics Agency awarded a delivery order valued at $8,437.40 to AmerisourceBergen Drug Corp for ProQuad vials on August 27, 2025, with an ultimate completion date of September 18, 2025. This firm fixed price delivery order represents a competitively awarded contract with no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. ProQuad is a combination vaccine used for immunization against measles, mumps, rubella,...